International Conference on Cell Signaling and Cancer Therapy

This track focuses on the intricate biology of cancer cells and their interactions within the tumor microenvironment. It aims to explore the cellular mechanisms that drive tumor progression and metastasis.

This session will delve into the latest advancements in the identification and validation of cancer biomarkers for diagnosis and prognosis. Emphasis will be placed on their clinical applications and implications for patient management.

This track will highlight cutting-edge technologies in cancer detection and imaging, including novel imaging modalities and techniques. Discussions will center on their potential to enhance early diagnosis and treatment outcomes.

This session will examine the role of tumor suppressor genes in cancer development and progression. Researchers will present findings on the molecular pathways and mechanisms that govern their function.

This track will investigate the role of protein kinases in cancer-related signal transduction pathways. It will cover their potential as therapeutic targets and the implications for cancer treatment.

This session will explore the impact of steroids and their receptors on cancer biology and therapy. Discussions will include the mechanisms of action and therapeutic implications of steroid signaling in various cancers.

This track will focus on the use of transgenic mouse models to study cancer biology and therapeutic responses. Researchers will share insights into how these models contribute to our understanding of cancer mechanisms.

This session will address the role of apoptosis in cancer and its regulation as a therapeutic strategy. Presentations will cover novel approaches to modulate apoptotic pathways in cancer treatment.

This track will explore the potential of RNA interference as a therapeutic approach in cancer biology. Discussions will focus on the challenges and successes of implementing RNAi in clinical settings.

This session will investigate the mechanisms of carcinogenesis and mutagenesis, highlighting the genetic and environmental factors involved. It aims to provide insights into prevention strategies and therapeutic interventions.

This track will showcase novel approaches to cancer therapeutics, including drug discovery and development processes. Emphasis will be placed on innovative strategies that enhance treatment efficacy and reduce resistance.